BCAT2 and Miyoshi myopathy: ELISA quantification revealed significantly elevated relative expression of CDKN1A protein in the MM cohort compared to healthy controls (p < 0.01), but the protein expression of BCAT2 exhibited comparable levels (p > 0.05).